Myocardial angiogenesis after chronic ghrelin treatment in a rat myocardial infarction model

Regulatory Peptides

Volumn 179, Issue 1-3, 2012, Pages 39-42

  Yuan, Ming Jie ^a   He Huang, ^a   Hu, Hong Yao ^a   Li Quan, ^a   Hong Jiang, ^a   Huang, Cong Xin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Ghrelin; Myocardial infarction; VEGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GHRELIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; GENE EXPRESSION; HEART INFARCTION; HEART INFARCTION SIZE; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PERICARDIOTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; THORACOTOMY; WESTERN BLOTTING;

ACTINS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CORONARY VESSELS; GENE EXPRESSION REGULATION; GENES, BCL-2; GHRELIN; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; KAPLAN-MEIER ESTIMATE; MALE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PERICARDIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THORACOTOMY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; RATTUS;

EID: 84866488692     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.08.013     Document Type: Article

References (26)

1. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res 2009, 81:482-490.
2. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L.M., Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001, 280:H2726-H2731.
3. Haider H., Akbar S.A., Ashraf M. Angiomyogenesis for myocardial repair. Antioxid Redox Signal 2009, 11:1929-1944.
4. Zhao T, Zhao W, Chen Y, Ahokas RA, Sun Y. Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc Res;80:188-94.
5. Siddiqui A.J., Blomberg P., Wardell E., Hellgren I., Eskandarpour M., Islam K.B., Sylven C. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 2003, 310:1002-1009.
6. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
7. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002, 87:2988.
8. Kishimoto I, Tokudome T, Hosoda H, Miyazato M, Kangawa K. Ghrelin and cardiovascular diseases. J Cardiol;59:8-13.
9. Iglesias M.J., Pineiro R., Blanco M., Gallego R., Dieguez C., Gualillo O., Gonzalez-Juanatey J.R., Lago F. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004, 62:481-488.
10. Huang C.X., Yuan M.J., Huang H., Wu G., Liu Y., Yu S.B., Li H.T., Wang T. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 2009, 30:2286-2291.
11. Wang L, Chen Q, Li G, Ke D. Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells. Peptides;33:92-100.
12. Ahluwalia A., Li A., Cheng G., Deng X., Tarnawski A.S. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol 2009, 60:29-34.
13. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001, 25:402-408.
14. Yuan M.J., Huang C.X., Tang Y.H., Wang X., Huang H., Chen Y.J., Wang T. A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur J Pharmacol 2009, 618:52-57.
15. Hao X., Mansson-Broberg A., Grinnemo K.H., Siddiqui A.J., Dellgren G., Brodin L.A., Sylven C. Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model. Cardiovasc Res 2007, 73:481-487.
16. Kajdaniuk D, Marek B, Foltyn W, Kos-Kudla B. Vascular endothelial growth factor (VEGF) - part 1: in physiology and pathophysiology. Endokrynol Pol;62:444-55.
17. Schwarz E.R., Speakman M.T., Patterson M., Hale S.S., Isner J.M., Kedes L.H., Kloner R.A. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol 2000, 35:1323-1330.
18. He Z., Opland D.M., Way K.J., Ueki K., Bodyak N., Kang P.M., Izumo S., Kulkarni R.N., Wang B., Liao R., Kahn C.R., King G.L. Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol 2006, 26:787-793.
19. Ackah E., Yu J., Zoellner S., Iwakiri Y., Skurk C., Shibata R., Ouchi N., Easton R.M., Galasso G., Birnbaum M.J., Walsh K., Sessa W.C. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 2005, 115:2119-2127.
20. Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T, Cao K, Yang Z, Kan YW, Su H. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci U S A;108:2064-9.
21. Zhou L., Ma W., Yang Z., Zhang F., Lu L., Ding Z., Ding B., Ha T., Gao X., Li C. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther 2005, 12:196-202.
22. Li A., Cheng G., Zhu G.H., Tarnawski A.S. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem Biophys Res Commun 2007, 353:238-243.
23. Chen L.L., Yin H., Huang J. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis. Cardiovasc Pathol 2007, 16:221-230.
24. Xu X., Jhun B.S., Ha C.H., Jin Z.G. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology 2008, 149:4183-4192.
25. Gao M, Yang J, Liu G, Wei R, Zhang L, Wang H, Wang G, Gao H, Chen G, Hong T. Ghrelin promotes the differentiation of human embryonic stem cells in infarcted cardiac microenvironment. Peptides;34:373-9.
26. Tse H.F., Yiu K.H., Lau C.P. Bone marrow stem cell therapy for myocardial angiogenesis. Curr Vasc Pharmacol 2007, 5:103-112.